After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Bristol-Myers Squibb Company (BMY) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $60.24. The Bristol-Myers Squibb Company has recorded 549,620 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
Bristol-Myers Squibb Company is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Bristol-Myers Squibb Company is $124.09B. A total of 9.68 million shares were traded on the day, compared to an average of 10.01M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, BMY has seen 2 BUY and 3 SELL insider trades, representing the acquisition of 11,242 and the disposition of 6,201 shares. Over the last 12 months, there were 96 BUYs and 62 SELLs from insiders. Insiders purchased 906,693 shares during that period but sold 963,343.
In the most recent transaction, Powell Ann sold 17,986 shares of BMY for 61.25 per share on Aug 24. After the transaction, the EVP, Chief Human Resources now owns 27,868 company shares. In a previous transaction on Aug 03, Plenge Robert M sold 732 shares at 61.14 per share. BMY shares that EVP, Chief Research Officer owns now total 6,584.
Among the insiders who sold shares, VESSEY RUPERT disposed of 50,385 shares on May 03 at a per-share price of $67.06. This resulted in the EVP & President, Research holding 47,751 shares of BMY after the transaction. In another insider transaction, Caforio Giovanni sold 240,000 shares at $74.65 per share on Feb 06. Company shares held by the Board Chair and CEO now total 236,104.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Bristol-Myers Squibb Company pays an annual dividend of $2.28, resulting in a dividend yield of 3.78%, and it has a price to earnings (P/E) ratio of 16.03. BMY’s most recent ex-dividend date was 7/6/2023 when it declared a $0.57 quarterly dividend that was paid in cash on 8/1/2023. Previously, the company paid the dividend on 5/1/2023 with an ex-dividend date of 4/6/2023. The BMY stock dividend was $0.57 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for BMY in the last 3 months, the mean price target is $73.04 with high estimates of $90.00 and low estimates of $56.00. In terms of 52-week highs and lows, BMY has a high of $81.43 and a low of $59.45.
As of this writing, BMY has an earnings estimate of $1.81 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of $2.09 per share and a lower estimate of $1.69. The company reported an EPS of $2.05 in the last quarter, which was 4.10% higher than expectations of $1.97.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BMY’s latest balance sheet shows that the firm has $13.98B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $15.28, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.67.
